AP
CME icon

Appleton Partners’s CME Group CME Stock Holding History

Appleton Partners’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.33M Sell
15,093
-1,029
-6% -$285K 0.2% 92
2026
Q1 		$4.76M Sell
16,122
-280
-2% -$83.2K 0.33% 77
2025
Q4 		$4.48M Buy
16,402
+23
+0.1% +$6.25K 0.3% 80
2025
Q3 		$4.42M Buy
16,379
+347
+2% +$94.4K 0.3% 78
2025
Q2 		$4.42M Sell
16,032
-238
-1% -$64.7K 0.31% 77
2025
Q1 		$4.32M Sell
16,270
-555
-3% -$137K 0.33% 78
2024
Q4 		$3.91M Buy
16,825
+272
+2% +$62.5K 0.29% 82
2024
Q3 		$3.65M Buy
16,553
+339
+2% +$70.1K 0.27% 86
2024
Q2 		$3.19M Sell
16,214
-27
-0.2% -$5.58K 0.25% 89
2024
Q1 		$3.5M Buy
16,241
+412
+3% +$86.5K 0.27% 88
2023
Q4 		$3.33M Sell
15,829
-519
-3% -$111K 0.27% 88
2023
Q3 		$3.27M Sell
16,348
-91
-0.6% -$18.1K 0.29% 83
2023
Q2 		$3.05M Sell
16,439
-996
-6% -$184K 0.26% 88
2023
Q1 		$3.34M Buy
17,435
+1,120
+7% +$203K 0.3% 83
2022
Q4 		$2.74M Buy
16,315
+64
+0.4% +$11.1K 0.26% 90
2022
Q3 		$2.88M Buy
16,251
+485
+3% +$95.8K 0.29% 86
2022
Q2 		$3.23M Sell
15,766
-20
-0.1% -$4.24K 0.31% 85
2022
Q1 		$3.75M Sell
15,786
-170
-1% -$39.9K 0.31% 88
2021
Q4 		$3.65M Buy
15,956
+138
+0.9% +$30.4K 0.27% 87
2021
Q3 		$3.06M Buy
15,818
+480
+3% +$97.2K 0.25% 93
2021
Q2 		$3.26M Sell
15,338
-9
-0.1% -$1.9K 0.28% 89
2021
Q1 		$3.13M Sell
15,347
-192
-1% -$37.8K 0.29% 86
2020
Q4 		$2.83M Buy
15,539
+115
+0.7% +$19.6K 0.28% 82
2020
Q3 		$2.58M Sell
15,424
-11
-0.1% -$1.85K 0.29% 81
2020
Q2 		$2.51M Sell
15,435
-10
-0.1% -$1.79K 0.3% 80
2020
Q1 		$2.67M Sell
15,445
-110
-0.7% -$21.9K 0.37% 70
2019
Q4 		$3.12M Buy
15,555
+266
+2% +$54.6K 0.34% 74
2019
Q3 		$3.23M Hold
15,289
– – 0.39% 70
2019
Q2 		$2.97M Buy
15,289
+190
+1% +$35K 0.37% 76
2019
Q1 		$2.48M Buy
15,099
+892
+6% +$158K 0.33% 85
2018
Q4 		$2.67M Sell
14,207
-457
-3% -$84.4K 0.4% 71
2018
Q3 		$2.5M Buy
14,664
+1,698
+13% +$286K 0.33% 86
2018
Q2 		$2.13M Buy
12,966
+2,132
+20% +$348K 0.3% 89
2018
Q1 		$1.75M Buy
10,834
+95
+0.9% +$15.1K 0.27% 101
2017
Q4 		$1.57M Buy
10,739
+773
+8% +$110K 0.24% 99
2017
Q3 		$1.35M Buy
9,966
+245
+3% +$30.9K 0.23% 102
2017
Q2 		$1.22M Sell
9,721
-62
-0.6% -$7.42K 0.2% 118
2017
Q1 		$1.16M Buy
9,783
+1,129
+13% +$136K 0.21% 103
2016
Q4 		$998K Buy
8,654
+902
+12% +$100K 0.2% 118
2016
Q3 		$810K Buy
7,752
+1,610
+26% +$168K 0.15% 133
2016
Q2 		$598K Buy
6,142
+2,472
+67% +$234K 0.12% 135
2016
Q1 		$353K Buy
+3,670
New +$334K 0.07% 163

Other funds holding CME

PAM
PineStone Asset Management Montreal, Quebec, Canada $16.2B AUM 25.74% 1-Year Est. Return
SP
Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
GAM
Guinness Asset Management London, United Kingdom $5.91B AUM 21.44% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
SLAM
Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
JSSH
J. Safra Sarasin Holding $6.97B AUM 32.91% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return

Appleton Partners's CME Position: Q2 2026 in Review

Appleton Partners reduced its CME Group (CME) stake by 6.4% in Q2 2026, selling an estimated $285K and leaving 15,093 shares worth $3.33M. The position accounts for 0.2% of the portfolio, ranked #92.

Appleton Partners first reported a position in CME in Q1 2016 and has held it in 42 quarters since. The position peaked at $4.76M in Q1 2026. 670 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Appleton Partners held 15,093 shares of CME Group worth $3.33M as of Q2 2026.
  • Appleton Partners sold 1,029 CME Group shares in Q2 2026, an estimated $285K.
  • CME Group made up 0.2% of Appleton Partners's portfolio in Q2 2026, its #92 holding.
  • Appleton Partners first reported a position in CME Group in Q1 2016 and has held it in 42 quarters since.
  • Appleton Partners's CME Group position peaked at $4.76M in Q1 2026.
  • 670 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Appleton Partners's 13F filing for Q2 2026, filed 21 Jul 2026.